Gyre Pharmaceuticals completed a Pre-NDA meeting with China’s CDE, which agreed that the existing Phase 3 clinical data support a conditional approval filing for Hydronidone and priority review ...
Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. In a move that could dramatically reshape the landscape for rare ...
On Sept. 30, the U.S. Food and Drug Administration conditionally approved the first injectable drug for the prevention and treatment of New World screwworm in cattle. The drug is produced by Zoetis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback